Tyler-Stone Wealth Management - ORAMED PHARMACEUTICALS INC ownership

ORAMED PHARMACEUTICALS INC's ticker is ORMP and the CUSIP is 68403P203. A total of 89 filers reported holding ORAMED PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.23 and the average weighting 0.0%.

Quarter-by-quarter ownership
Tyler-Stone Wealth Management ownership history of ORAMED PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$10.0%3000.0%0.00%0.0%
Q2 2023$1
-75.0%
3000.0%0.00%
-66.7%
Q4 2022$4
-99.8%
3000.0%0.00%
+50.0%
Q3 2022$2,000
+100.0%
3000.0%0.00%
+100.0%
Q2 2022$1,000
-66.7%
3000.0%0.00%
-50.0%
Q1 2022$3,000
-25.0%
3000.0%0.00%0.0%
Q4 2021$4,0003000.00%
Other shareholders
ORAMED PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
MORGAN JESS S & CO INC 366,401$2,374,0002.07%
Private Portfolio Partners LLC 67,400$436,7520.12%
Knoll Capital Management, LLC 20,000$130,0000.08%
ETF MANAGERS GROUP, LLC 94,493$612,0000.02%
Virtu Financial LLC 21,526$139,0000.01%
OCCUDO QUANTITATIVE STRATEGIES LP 21,904$142,0000.01%
BOURGEON CAPITAL MANAGEMENT LLC 5,627$36,0000.01%
Walleye Capital LLC 78,418$508,0000.01%
Jump Financial, LLC 36,100$234,0000.01%
Plante Moran Financial Advisors, LLC 7,911$51,0000.01%
View complete list of ORAMED PHARMACEUTICALS INC shareholders